Adverum Biotechnologies: Q4 Earnings Snapshot
Adverum Biotechnologies: Q3 Earnings Snapshot
Adverum Biotechnologies: Q2 Earnings Snapshot
Adverum Biotechnologies: Q1 Earnings Snapshot
Here is how Adial Pharmaceuticals, Inc. (ADIL) and Adverum Biotechnologies (ADVM) have performed compared to their sector so far this year.
Stocks that traded heavily or had substantial price changes Friday: Rumble, Braze rise; Virgin Orbit, Sientra fall
Adverum Biotechnologies: Q4 Earnings Snapshot
Adverum Biotechnologies: Q3 Earnings Snapshot
Adverum (ADVM) initiates dosing in the phase II LUNA study, currently investigating its lead product candidate ixoberogene soroparvovec for wet age-related macular degeneration.
REDWOOD CITY, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish...